Complete Mounjaro vs Wegovy Dosage Comparison Guide
Mounjaro vs Wegovy Dosage: Key Differences In Stock UK
Understanding the dosage differences between Mounjaro and Wegovy is crucial for making an informed treatment choice. Wegovy follows a structured 5-dose escalation over 16 weeks, starting at 0.25mg and increasing to a maintenance dose of 2.4mg. Mounjaro employs a different schedule with 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg doses over approximately 20 weeks. Both treatments require gradual dose increases to minimise potential side effects and allow your body to adapt.
The fundamental difference lies in their mechanisms: Wegovy contains semaglutide (a GLP-1 receptor agonist), whilst Mounjaro contains tirzepatide (a dual GIP/GLP-1 receptor agonist). This impacts not only the dosing schedule but also how each treatment may support your weight management goals. At EverydayMeds, we stock both complete dose ranges, ensuring seamless progression through your prescribed escalation schedule without supply interruptions.
Wegovy Dosage Schedule and Pricing In Stock
Wegovy's dosage progression follows a clinically-proven 16-week escalation schedule. Weeks 1-4 utilise the 0.25mg starter dose (£79.99), followed by 0.5mg for weeks 5-8 (£94.99), then 1mg for weeks 9-12 (£99.99), and 1.7mg for weeks 13-16 (£139.99). The maintenance dose of 2.4mg begins at week 17 and continues long-term at £209.99 per pen. This structured approach allows your body to gradually adapt whilst minimising gastrointestinal side effects commonly associated with GLP-1 treatments.
For added convenience, our Getting Started Bundles combine consecutive doses: the Intro Duo (0.25mg & 0.5mg) costs £169.99, whilst the Progress Duo (0.5mg & 1mg) is available for £189.99. These bundles eliminate the need for multiple orders during your initial treatment phase. New customers can apply discount code FIRST40 at checkout, whilst returning customers use DOSE25 to access these competitive prices across our full Wegovy range.
Clinical Evidence Comparing Mounjaro vs Wegovy Dosage Outcomes
The STEP clinical trial programme demonstrated Wegovy's efficacy across its dose escalation schedule. In STEP 1, participants achieved an average weight loss of approximately 15% at 68 weeks when using the full dose progression alongside lifestyle modifications (Wilding et al., NEJM, 2021). The dose escalation protocol proved essential for treatment tolerability and optimal outcomes. STEP 2 showed that even in participants with type 2 diabetes, the structured dosing schedule supported meaningful weight management.
Mounjaro's clinical evidence comes from the SURMOUNT trial series, demonstrating the effectiveness of tirzepatide's unique dosing approach. However, direct comparison between trials isn't appropriate due to different study designs, populations, and endpoints. What remains clear is that both medications require careful dose escalation and ongoing medical supervision to achieve optimal results whilst minimising side effects.
How Wegovy's Mechanism Influences Mounjaro vs Wegovy Dosage Decisions
Wegovy works as a GLP-1 receptor agonist, mimicking the natural incretin hormone glucagon-like peptide-1. This mechanism triggers satiety signals in the brain, reduces appetite, and slows gastric emptying, helping you feel fuller for longer after meals. The gradual dose escalation allows these effects to develop progressively, reducing the likelihood of nausea or other gastrointestinal side effects. Wegovy specifically targets appetite regulation centres in the hypothalamus, which may explain why the structured dose increases are necessary for sustained effectiveness. The once-weekly injection schedule maintains consistent blood levels throughout your treatment journey.
Streamlined Ordering Process for Mounjaro vs Wegovy Dosage Options
Accessing either treatment through EverydayMeds involves a straightforward 3-minute online clinical assessment. Our qualified prescribers review your submission within 3 working days (or 24 hours with express service), determining which medication and dosing schedule aligns with your clinical needs and weight management goals. Once approved, your chosen treatment ships via next-day delivery using our temperature-controlled cold-chain system. This process ensures medication integrity from our GPhC-registered pharmacy (#9012878) directly to your door. Whether you require Wegovy's structured escalation or Mounjaro's alternative dosing protocol, we maintain consistent stock levels to support uninterrupted treatment.
Storage Advantages in Mounjaro vs Wegovy Dosage Planning
Storage requirements differ between these treatments and may influence your dosage choice. Wegovy pens must be stored in the refrigerator at 2-8°C before first use, but offer exceptional travel flexibility with 6 weeks of room temperature storage below 30°C once removed. Mounjaro provides only 21 days of room temperature storage, making Wegovy more suitable if you frequently travel or prefer flexible storage options. Both medications arrive in temperature-controlled packaging, ensuring efficacy from the moment they reach your location. The FlexTouch pen design for Wegovy provides consistent dose delivery across all strength options, from the 0.25mg starter through to 2.4mg maintenance doses.
Stock Availability Advantage for UK Mounjaro vs Wegovy Dosage Seekers
Historically, Wegovy availability in the UK has faced intermittent supply challenges, leaving many patients frustrated with treatment interruptions. EverydayMeds has established a robust supply chain partnership with Novo Nordisk, ensuring reliable stock levels across all five Wegovy doses throughout 2026. Our inventory management system tracks dose progression requirements, automatically flagging when patients approach their next escalation phase. This proactive approach prevents treatment gaps that could compromise your weight management progress.
Unlike some providers who may only stock popular doses, we maintain full range availability from starter 0.25mg through maintenance 2.4mg doses. Our ordering system allows advance purchases of your next required dose, ensuring seamless progression through your prescribed escalation schedule. This comprehensive stock approach means you can confidently begin treatment knowing your entire dose journey is supported without supply-related interruptions.
Final Decision Support for Mounjaro vs Wegovy Dosage Selection
Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which dosing approach aligns with your individual circumstances. Factors including your medical history, lifestyle requirements, and treatment goals all influence this decision. Our clinical assessment captures these nuances, ensuring your prescribed treatment matches your specific needs. Whether you proceed with Wegovy's established semaglutide dosing or explore Mounjaro's tirzepatide alternative, consistent supply and professional support remain paramount. Visit https://everydaymeds.co.uk/collections/wegovy to begin your clinical assessment, applying discount codes FIRST40 (new customers) or DOSE25 (returning customers) at checkout for optimised pricing.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
